Archives
-
Praeruptorin A Assay Design Guide
2026-08-28
A scenario-based guide to using Praeruptorin A (SKU N2885) in cell viability, proliferation, cytotoxicity, inflammation, and ferroptosis workflows. It addresses stock preparation, concentration selection, assay interpretation, cross-domain limitations, and practical supplier evaluation.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-08-27
The reference study shows that intestinal epithelial TM6SF2 protects against metabolic dysfunction-associated steatohepatitis by maintaining barrier function and regulating host–microbe communication. Conditional knockout, fecal transplantation, co-housing, and pharmacological experiments connect intestinal lipid handling to pathobiont enrichment and lysophosphatidic acid signaling in the liver.
-
EZ Cap Cy5 Firefly Luciferase mRNA Lab Guide
2026-08-27
Learn how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, can resolve common assay problems involving transfection variability, cellular uptake, translation, and ATP-dependent viability readouts. This scenario-based guide connects dual fluorescence–luminescence reporting with practical handling, optimization, interpretation, and vendor-selection decisions.
-
DAPT (GSI-IX) for Notch Signaling Workflows
2026-08-26
DAPT (GSI-IX) provides a practical way to test whether γ-secretase-dependent Notch activity contributes to angiogenesis, tumor biology, immune regulation, or APP processing. This workflow-focused guide connects pathway inhibition with assay design, controls, troubleshooting, and translational interpretation.
-
Firefly Luciferase mRNA as a Delivery Readout
2026-08-26
Firefly Luciferase mRNA can do more than report gene expression: it can help separate delivery, translation, and immune effects in mRNA experiments. This guide uses the R1013 design and recent nanovaccine evidence to build more informative assay workflows.
-
OMVs Enable Rapid Display of mRNA Tumor Antigens
2026-08-25
The reference study developed genetically engineered outer membrane vesicles that rapidly bind sequence-tagged mRNA antigens and promote dendritic-cell cross-presentation. This Plug-and-Display system produced strong antitumor effects in mouse models, while highlighting a delivery strategy that differs from lipid nanoparticle encapsulation for personalized mRNA vaccination.
-
Engineering Better mRNA Readouts with Firefly Luciferase
2026-08-25
A mechanistic and strategic guide to using Cap1-capped, 5-moUTP modified mRNA as a controlled reporter payload for translation studies, delivery-vector benchmarking, and translational imaging workflows.
-
Synthetic Efferocytic Microglia for Amyloid-β Clearance
2026-08-24
Shao and colleagues engineered a synthetic efferocytic receptor that redirected microglia toward amyloid-β clearance while promoting anti-inflammatory signaling in a mouse model of Alzheimer’s disease. The study combines receptor engineering with microglia-directed mRNA lipid nanoparticles, providing a framework for in situ immune-cell reprogramming rather than systemic antibody-mediated activation.
-
EZ Cap™ Cas9 mRNA for Neurodegeneration Models
2026-08-24
Build fast, transient CRISPR-Cas9 perturbation workflows for zebrafish and cell-based neurodegeneration studies with a Cap1-, 5-moUTP-modified Cas9 transcript. The workflow connects Fyn–Stat3 biology to practical functional gene studies while emphasizing dose control, RNA integrity, and phenotype-specific validation.
-
TPCA-1 in Septic AKI NF-κB Research
2026-08-23
Explore how TPCA-1, a selective IKK-2 inhibitor, can be used to interrogate the NF-κB/Apaf1/caspase-9/autophagy axis in septic acute kidney injury. This mechanistic guide translates recent renal biology into practical assay and experimental-design decisions.
-
WAY-100635 in Reliable Viability Assays
2026-08-22
Learn how WAY-100635 (SKU A3933) can function as a mechanistic 5-HT1A control in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, solvent handling, interpretation of receptor-dependent effects, and practical vendor selection.
-
Cy7 NHS Ester: Practical Labeling Protocol
2026-08-21
Cy7 NHS ester is a sulfonated, water-soluble protein labeling dye for attaching near-infrared fluorescence to primary amines on proteins and peptides. It is useful for near-infrared fluorescent imaging and biomolecule conjugation, but it is not intended for long-term storage of reagent solutions or labeling strategies that do not target amino groups.
-
EGCG Nanoparticles Boost FLASH Radiotherapy
2026-08-21
A 2026 International Journal of Nanomedicine study reports that functionalized, self-assembled epigallocatechin gallate nanoparticles, termed BENPs, can intensify FLASH radiotherapy-induced oxidative stress and tumor injury while stimulating antitumor immune responses. The work connects radiosensitization with immune remodeling and provides a framework for combining DNA damage measurements, tumor efficacy, and systemic safety assessment.
-
Fulvestrant: From ER Biology to Translation
2026-08-20
Fulvestrant (ICI 182,780) offers more than ER blockade: it enables translational researchers to connect ERα degradation, MDM2 protein turnover, chemotherapy sensitization, and endocrine therapy resistance research while defining the limits of cross-domain inference.
-
Firefly Luciferase mRNA: 5-moUTP and Cap1 Design
2026-08-20
Firefly Luciferase mRNA R1013 is a Cap1-capped, 5-moUTP modified mRNA for transient luciferase expression and bioluminescent reporter assays. Its defined 1921-nucleotide transcript, approximately 100-nucleotide poly(A) tail, and 1 mg/mL formulation support standardized mRNA delivery and translation efficiency assay workflows.